subgroup of
drug)
→
ReceivesAction
→
protected by patent
| Typicality: | 0.462 |
| Saliency: | 0.270 |
| new drug → be protected by → patent | 6 |
| new drug → be developed under → patent protection | 3 |
| negative | neutral | positive |
| 0.096 | 0.710 | 0.194 |
| Raw frequency | 9 |
| Normalized frequency | 0.270 |
| Modifier score | 0.800 |
| Perplexity | 75.629 |